FDA, industry not waiting for Congress on drug shortages

Few expect Congress to produce a quick solution to the problem of shortages, which remain an immediate threat to patient care


American Medical News

WASHINGTON — The Obama administration is permitting importation of one critical drug while a new third-party group seeks to help generic drugmakers coordinate to avoid shortages.

Pending legislation in Congress and efforts by the private sector aimed at reducing national drug shortages largely aim to improve communication among manufacturers, distributors, federal regulators, hospitals and physicians to prevent supply problems from arising in the first place.

LexisNexis Copyright © 2013 LexisNexis, a division of Reed Elsevier Inc. All rights reserved.   
Terms and Conditions Privacy Policy

Full story: FDA, industry not waiting for Congress on drug shortages

  1. Tags
  2. Medical / Clinical

Recommended Medical / Clinical

Join the discussion